Kennedy Pledges to Add Follow-On Biologics Bill to PDUFA Reauthorization

Drug Industry Daily
A A
Sen. Edward Kennedy (D-Mass.) vowed to attach a bill allowing an abbreviated pathway for the FDA to approve follow-on biologic products to legislation reauthorizing the Prescription Drug User Fee Act (PDUFA).

To View This Article:

Login

Subscribe To Drug Industry Daily